Feb 13, 2012 | Medical News
Bristol-Myers completes tender offer for Inhibitex
Bristol-Myers Squibb Company announced today the successful completion of the tender offer by Bristol-Myers Squibb Company for all of the outstanding shares of common stock of Inhibitex, Inc.
BUYINS.NET: TRLG, ANR, CMRG, MCHX, INHX, EFSC Are Seasonally Ripe To Go Up In the Next Five Weeks
Feb 10, 2012 -- BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of TRUE RELIGION APPAREL INC.
Gilead Up 6% After Positive Hep-C Trial
Though guidance for the year had been weaker than expected after a down fourth quarter, Gilead's research chief announce results of their anti-hepatitis C treatment.
J.C. Penney, Jazz Pharma and Healthspring Lead These 52-Week High Stocks Today
Advance Auto Parts : UBS upgraded Advance Auto Parts based on expectations for improved operating performance due to its streamlined focus.
Inhibitex (INHX) Shares Downgraded to "Market Perform" by William Blair Analysts
Inhibitex was downgraded by equities research analysts at William Blair from an "outperform" rating to a "market perform" rating in a research note issued to investors on Monday.